Literature DB >> 26888580

Adenosine diphosphate platelet dysfunction on thromboelastogram is independently associated with increased morality in traumatic brain injury.

M J Daley1,2, Z Enright3,4, J Nguyen3,4, S Ali5, A Clark5, J D Aydelotte5,6, P G Teixeira5,6, T B Coopwood5,6, C V R Brown5,6.   

Abstract

PURPOSE: The purpose of this study is to determine if adenosine diphosphate (ADP) platelet dysfunction on thromboelastogram (TEG) is associated with increased in-hospital mortality in patients with head trauma. The hypothesis is that ADP dysfunction is associated with increased mortality.
METHODS: This retrospective review evaluated trauma patients admitted to a level 1 trauma center from February 2011 to October 2013 who received a TEG. Patients were included if the TEG was drawn within the first 24 h of admission and the head abbreviated injury score was greater than or equal to three. Patients were categorized as severe ADP dysfunction if the degree of ADP inhibition on TEG exceeded 60 %.
RESULTS: A total of 90 patients were included (no ADP dysfunction n = 37; ADP dysfunction n = 53). Initial Glasgow Coma Scale [GCS (12 ± 4 vs. 11 ± 5; p = 0.26)] and use of pre-injury antiplatelet agents (30 vs. 28 %; p = 0.88) were similar. Patients with ADP dysfunction on TEG had a higher in-hospital mortality rate (8 vs. 32 %; p < 0.01). ADP dysfunction was independently associated with in-hospital mortality upon fixed logistic regression (OR 6.2; 95 % CI 1.2-33) while controlling for age, gender, hypotension, pre-injury antiplatelet agents, GCS and Injury Severity Score.
CONCLUSION: ADP dysfunction on TEG is associated with increased mortality in patients with traumatic brain injury.

Entities:  

Keywords:  Platelet dysfunction; TEG; Thromboelastogram; Traumatic brain injury

Mesh:

Substances:

Year:  2016        PMID: 26888580     DOI: 10.1007/s00068-016-0643-z

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  29 in total

1.  Predicting intracranial lesions by antiplatelet agents in subjects with mild head injury.

Authors:  Andrea Fabbri; Franco Servadei; Giulio Marchesini; Sherman C Stein; Alberto Vandelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-18       Impact factor: 10.154

2.  Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage.

Authors:  Andrew M Naidech; Storm M Liebling; Neil F Rosenberg; Paul F Lindholm; Richard A Bernstein; H Hunt Batjer; Mark J Alberts; Hau C Kwaan
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

3.  The significance of platelet count in traumatic brain injury patients on antiplatelet therapy.

Authors:  Bellal Joseph; Viraj Pandit; David Meyer; Lynn Butvidas; Narong Kulvatunyou; Mazhar Khalil; Andrew Tang; Bardiya Zangbar; Terence O'Keeffe; Lynn Gries; Randall S Friese; Peter Rhee
Journal:  J Trauma Acute Care Surg       Date:  2014-09       Impact factor: 3.313

4.  Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy.

Authors:  Chad W Washington; Douglas J E Schuerer; Robert L Grubb
Journal:  J Trauma       Date:  2011-08

5.  Incidence and predictors of intracranial hemorrhage after minor head trauma in patients taking anticoagulant and antiplatelet medication.

Authors:  Edward S Brewer; Boris Reznikov; Rebecca F Liberman; Richard A Baker; Michael S Rosenblatt; Carlos A David; Sebastain Flacke
Journal:  J Trauma       Date:  2011-01

6.  A retrospective review of patients with head injury with coexistent anticoagulant and antiplatelet use admitted from a UK emergency department.

Authors:  J Major; M J Reed
Journal:  Emerg Med J       Date:  2009-12       Impact factor: 2.740

7.  Acquired dysfunction due to the circulation of "exhausted" platelets.

Authors:  F I Pareti; A Capitanio; L Mannucci; C Ponticelli; P M Mannucci
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

8.  Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats.

Authors:  Francis J Castellino; Michael P Chapman; Deborah L Donahue; Scott Thomas; Ernest E Moore; Max V Wohlauer; Braxton Fritz; Robert Yount; Victoria Ploplis; Patrick Davis; Edward Evans; Mark Walsh
Journal:  J Trauma Acute Care Surg       Date:  2014-05       Impact factor: 3.313

Review 9.  Management of bleeding and coagulopathy following major trauma: an updated European guideline.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

Review 10.  Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options.

Authors:  Marc Maegele
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

View more
  6 in total

Review 1.  Thromboelastography and rotational thromboelastometry for the surgical intensivist: A narrative review.

Authors:  Byron C Drumheller; Deborah M Stein; Laura J Moore; Sandro B Rizoli; Mitchell J Cohen
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

Review 2.  Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury.

Authors:  Jianning Zhang; Fangyi Zhang; Jing-Fei Dong
Journal:  Blood       Date:  2018-03-05       Impact factor: 22.113

3.  Nonhuman primate model of polytraumatic hemorrhagic shock recapitulates early platelet dysfunction observed following severe injury in humans.

Authors:  Leasha J Schaub; Hunter B Moore; Andrew P Cap; Jacob J Glaser; Ernest E Moore; Forest R Sheppard
Journal:  J Trauma Acute Care Surg       Date:  2017-03       Impact factor: 3.313

4.  The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Jacques Duranteau; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Marc Maegele; Giuseppe Nardi; Louis Riddez; Charles-Marc Samama; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2019-03-27       Impact factor: 9.097

5.  A Prognostic Model Incorporating Red Cell Distribution Width to Platelet Ratio for Patients with Traumatic Brain Injury.

Authors:  Ruoran Wang; Min He; Jing Zhang; Shaobo Wang; Jianguo Xu
Journal:  Ther Clin Risk Manag       Date:  2021-11-26       Impact factor: 2.423

6.  Effects of Guideline-Based Correction of Platelet Inhibition on Outcomes in Moderate to Severe Isolated Blunt Traumatic Brain Injury.

Authors:  Andrew B Sorah; Kyle Cunningham; Huaping Wang; Colleen Karvetski; Michael Ekaney; Rita Brintzenhoff; Susan Evans
Journal:  Neurotrauma Rep       Date:  2022-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.